Terrence Donnelly Heart Center, Division of Cardiology, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.
Am Heart J. 2010 Apr;159(4):605-11. doi: 10.1016/j.ahj.2010.01.014.
In-hospital assessment of left ventricular ejection fraction (LVEF) in non-ST-segment elevation acute coronary syndrome (NSTE-ACS) is emphasized in current practice guidelines. There are limited data regarding the evaluation of LVEF and clinical characteristics and in-hospital management in the "real world."
Registries including the Canadian Acute Coronary Syndrome (ACS) I and II, Global Registry of Acute Coronary Events (main GRACE/expanded GRACE(2)), and Canadian Registry of Acute Coronary Events (CANRACE) enrolled 13,703 NSTE-ACS patients across Canada between 1999 and 2008. Patients were stratified by in-hospital LVEF measurement, and LVEF was categorized as normal, mildly, or moderately to severely impaired. We compared clinical characteristics, cardiac procedures, and clinical outcomes across these groups. Multivariable logistic regression identified factors independently associated with the assessment of LVEF.
Overall, 8,116 patients (59.2%) had LVEF measurement, and of the 7,667 patients with available LVEF data, 4,470 (58.3%) had normal, 1,916 (25%) mildly impaired, and 1,281 (16.7%) moderately to severely impaired LVEF. Patients with LVEF assessment more frequently (all P < .001) underwent cardiac catheterization, percutaneous coronary intervention or coronary bypass surgery, and had higher (both P < .001) rates of myocardial (re) infarction and heart failure. In-hospital reinfarction, higher Killip class, abnormal biomarker, hospital stay >10 days, and on-site cardiac catheterization facility were independently associated with LVEF assessment. Despite increasing LVEF assessment over time (P for trend < .001), 31.2% of patients in the most recent registry (2008) had no in-hospital LVEF assessment.
In-hospital LVEF assessment is not performed in many NSTE-ACS patients. The LVEF assessment, associated with increased use of evidence-based therapies and invasive cardiac procedures, was obtained more frequently in patients with myocardial (re) infarction, heart failure on presentation, and prolonged hospital stay.
在现行实践指南中,非 ST 段抬高型急性冠脉综合征(NSTE-ACS)患者强调住院期间左心室射血分数(LVEF)的评估。关于 LVEF 的评估以及“真实世界”中的临床特征和住院管理,相关数据有限。
1999 年至 2008 年间,加拿大急性冠脉综合征(ACS)I 和 II 登记处、全球急性冠脉事件登记处(主要 GRACE/扩展 GRACE(2))和加拿大急性冠脉事件登记处(CANRACE)共纳入了 13703 例加拿大 NSTE-ACS 患者。根据住院期间 LVEF 测量值对患者进行分层,将 LVEF 分为正常、轻度、中度至重度降低。我们比较了这些组的临床特征、心脏手术和临床结局。多变量逻辑回归确定了与 LVEF 评估相关的独立因素。
共有 8116 例患者(59.2%)进行了 LVEF 测量,在有可用 LVEF 数据的 7667 例患者中,4470 例(58.3%)LVEF 正常,1916 例(25%)轻度受损,1281 例(16.7%)中度至重度受损。进行 LVEF 评估的患者更频繁地(均 P<.001)接受了心脏导管插入术、经皮冠状动脉介入治疗或冠状动脉旁路手术,并且心肌(再)梗死和心力衰竭的发生率更高(均 P<.001)。住院期间再梗死、更高的 Killip 分级、异常生物标志物、住院时间>10 天和现场心脏导管插入术设施与 LVEF 评估独立相关。尽管随着时间的推移,LVEF 评估的比例逐渐增加(趋势 P<.001),但在最近的登记处(2008 年)中,仍有 31.2%的患者未进行住院期间 LVEF 评估。
许多 NSTE-ACS 患者未进行住院 LVEF 评估。LVEF 评估与更频繁地使用基于证据的治疗方法和有创性心脏手术相关,在出现心肌(再)梗死、心力衰竭和延长住院时间的患者中更为常见。